Adjunctive nano‐curcumin therapy improves inflammatory and clinical indices in children with cystic fibrosis: A randomized clinical trial

Inflammation may develop due to internal dysfunction of the cystic fibrosis transmembrane conductance regulator (CFTR) protein or external factors in patients with cystic fibrosis (CF). This prospective randomized clinical trial aimed to ascertain the effects of nano‐curcumin as an anti‐inflammatory...

Descripción completa

Detalles Bibliográficos
Autores principales: Talebi, Saeedeh, Day, Andrew S., Safarian, Mahammad, Sayedi, Seyed Javad, Jaafari, Mahmood Reza, Abbasi, Zahra, Barghchi, Hanieh, Kianifar, Hamid Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261803/
https://www.ncbi.nlm.nih.gov/pubmed/37324924
http://dx.doi.org/10.1002/fsn3.3323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261803/
https://www.ncbi.nlm.nih.gov/pubmed/37324924
http://dx.doi.org/10.1002/fsn3.3323

Ejemplares similares